Table: Shin Nippon Biomedical - 9-MTH group results

Shin Nippon Biomedical Laboratories

06/02/2026 24:00

Feb 6 (Reuters)- 
             Shin Nippon Biomedical Laboratories Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2025        Dec 31, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             21.20               22.24            30.70    
                 (-4.7 pct)          (+23.6 pct)      (-5.2 pct)  
  Operating          1.03                1.89             2.60    
                 (-45.7 pct)         (-25.3 pct)      (-12.8 pct) 
  Recurring          3.12                4.14             5.35    
                 (-24.6 pct)         (-15.3 pct)      (-17.0 pct) 
  Net                2.27                3.21             3.56    
                 (-29.2 pct)         (-15.5 pct)      (-27.6 pct) 
  EPS             54.54 yen           76.99 yen        85.53 yen  
  Ann Div                             50.00 yen        50.00 yen  
  -Q2 div         20.00 yen           20.00 yen                   
  -Q4 div                             30.00 yen        30.00 yen  
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T